| 1/5 | US=64 / Câncer Heffner LT. Staging in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 3-7. (Comtemporary Hematology) ISBN 978-1-934115-82-4. MIELOMA MULTIPLO; TERAPIA-ALVO; MEDICINA TRADUCAO; BIOINFORMATICA; ACIDO TRANS-RETINOICO; GIST; IMATINIB; DASATINIBE; EPIGENETICA; DECITABINA; DETER HIPOTESE CELULAR |
| 2/5 | US=69 / Câncer Wheler J, Kurzrock R. Perspectives: bench to bedside and back. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 1-19. ISBN 978-1-60327-423-4. TERAPIA DE CANCER DIRECIONADA; MEDICINA TRANSLACIONAL; BIOINFORMATICA; ACIDO TRANS-RETINOICO; GIST; IMATINIB; DASATINIBE; EPIGENETICA; DECITABINA; DETER HIPOTESE CELULAR |
| 3/5 | US=69 / Câncer Quintás-Cardama A, Kantarjian H, Garcia-Manero G, Cortes J. Targeted therapy in myelodysplastic syndrome. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 237-60. ISBN 978-1-60327-423-4. TERAPIA-ALVO; SINDROME MIELODISPLASICA; DECITABINA; A METILACAO DO DNA; 5-AZACITIDINA; LENALIDOMIDA |
| 4/5 | US=84-A / Biol/Mol Ammanamanchi S, Brattain MG. Transformig growth factor-B in developing and advanced cancers: DNA methylation and histone deacetylation inhibitors as potential therapeutic agents for the reconstitution of TGF-B signaling in breast cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 463-74. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. METILACAO DO DNA; DECITABINA; DESACETILACAO DAS HISTONAS; RII; TGF-B RECEPTOR TIPO II; SP FAMILIA DE GENES; TRICOSTATINA A |
| 5/5 | US=35 / Câncer Fandy T, Carraway H, Gore SD. Molecular therapeutics of AML: modulating gene expression as a therapeutic approach in the treatment of AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 275-91. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOIDE AGUDA; METILACAO DO DNA; AGENTE DEMETILANTE; 5-AZACITIDINA; INIBIDOR DA HISTONA DEACETILASE; PROMOTOR HIPER-METILACAO; HISTONA ACETILTRANSFERASE; HISTONA METILTRANSFERASE; DECITABINA |